Texas Instruments Drops as Tariff Fears Weigh on Sales Outlook

Texas Instruments Drops as Tariff Fears Weigh on Sales Outlook

Texas Instruments Inc., a prominent chipmaker supplying critical components for automotive and industrial equipment manufacturers, experienced a significant drop in its stock price during late trading following a conference call that raised concerns about the sustainability of recent sales growth. The stock tumbled by more than 11% as executives grappled with analyst skepticism regarding the company’s outlook. This volatility underscores the ongoing uncertainty surrounding the impact of trade tariffs and their influence on demand within the semiconductor industry.

The company’s third-quarter forecast, which exceeded most analyst estimates, failed to fully reassure investors. Revenue is projected to be between $4.45 billion and $4.8 billion, representing a deceleration in growth compared to the previous period, and slightly below the average anticipated revenue of $4.57 billion. Profit forecasts indicate approximately $1.48 per share, also below the projected average of $1.50. Despite these figures, the stock reacted negatively, reflecting anxieties about the underlying drivers of company performance.

A key source of concern centers on the extent to which recent sales gains are attributable to “pull-in” demand – customers proactively purchasing components to mitigate the impact of tariffs. The company’s Chief Financial Officer, Rafael Lizardi, stated, “We have 100,000 customers. We don’t really know.” This lack of clarity regarding the true drivers of revenue signals a fundamental uncertainty within the market and a potential instability in future sales.

Executives emphasized confidence in improvements across all markets, except for the automotive sector, which remains a slower-healing area. Chief Executive Officer Haviv Ilan noted that “Automotive has not recovered yet.” This observation highlights the sensitivity of the company’s business to external economic factors and geopolitical tensions. The company’s cautious approach is attributed to initial strong orders observed during the second quarter, where some customers were stockpiling inventory in anticipation of tariff-related price increases. However, these levels have since returned to normal recovery periods, indicating a softening in the urgency surrounding the tariff issue.

Analysts repeatedly pressed management on a perceived shift towards a more pessimistic outlook. The company’s response, emphasizing their confidence in long-term growth prospects, did little to alleviate concerns. Texas Instruments anticipates continued overall growth in chip demand, bolstered by the increasing integration of semiconductors into a broader range of products. However, the escalating US-China rivalry and the Trump administration’s tariffs continue to cast a shadow over the industry, impacting pricing and potentially slowing down demand.

The company’s strategic response includes significant investment in new production facilities, including four plants outside of the US, one located in China, and new factories in the Dallas area and Utah. This expansion is aimed at bolstering resilience and providing alternatives in a world of growing trade barriers. Nevertheless, these investments are currently impacting cash flow and profitability, and the company intends to refocus on shareholder returns once the new facilities are operational. Texas Instruments holds a leading position in the market for analog chips, characterized by its comprehensive product line and extensive customer base, making its reports a crucial indicator of demand within a diverse range of industries. These developments will be closely watched by investors as the company navigates the complex landscape of global trade and technological innovation.

©2025 Bloomberg L.P.

THIS CONTENT IS CURRENTLY LOCKED.

ApexDator is scheduled to launch in 2026.

Contact the organization’s assistant to receive early access and related benefits in advance, including AI-powered stock picks, signals, and expert-backed research as features roll out.